EPICRISPR BIOTECHNOLOGIES
Dead / Abandoned — Abandoned — no statement of use filed (as of 29 Sept 2025)
What this means for you
This application is over — abandoned 29 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98125106
- Mark type
- Design + words
- Filed
- 09 Aug 2023
- Published for opposition
- 31 Dec 2024
- Abandoned
- 29 Sept 2025
- Attorney of record
- Salima A. Merani, Ph.D.
Goods and services
- Class 042 — Scientific and technological services: Research and development services, all of the foregoing in the fields of gene regulation and epigenetics and the use of CRISPR technology in relation thereto; Medical research services, namely, development of genetic medicine therapies, all of the foregoing in the fields of gene regulation and epigenetics and the use of CRISPR technology in relation thereto; provision of medical research and scientific research information in the field of gene regulation and epigenetics and the use of CRISPR technology in relation thereto
Owner
- Epicrispr Biotechnologies, Inc., South San Francisco, CA, US
- Epicrispr Biotechnologies, Inc., South San Francisco, CA, US
Prosecution history
- 29 Sept 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 Sept 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Jan 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Jan 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2024 — PUBLISHED FOR OPPOSITION
- 25 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Nov 2024 — ASSIGNED TO LIE
- 13 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Aug 2024 — NOTICE OF REVIVAL - E-MAILED